Digest Network Come funziona
Network
/
Società
Ca
Non verificato

Capstan Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaOncologiaSalute

5 comunicati stampa

Guarda tutti i comunicati
11/06/2025
Scienza
Biotecnologia
Medicina - Varie
Salute
Farmaceutica
Sanità
Industria
Capstan Therapeutics Announces Initiation of Phase 1 Trial of Lead In Vivo CAR-T Therapy, CPTX2309, for Treating Autoimmune Disease
Fonte
Capstan Therapeutics, Inc.
Emittente
Business Wire
1.00
0
18/11/2024
Oncologia
Salute
Biologia
Biotecnologia
Farmaceutica
Eventi
Fiere
Capstan Therapeutics Presents Preclinical Data on Lead In Vivo CAR-T Candidate, CPTX2309, at American College of Rheumatology (ACR) Convergence 2024
Fonte
Capstan Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/11/2024
Eventi
Fiere
Oncologia
Salute
Biologia
Biotecnologia
Farmaceutica
Capstan Therapeutics to Participate in Upcoming Investor Conferences
Fonte
Capstan Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/09/2024
Eventi
Biotecnologia
Salute
Capstan Therapeutics to Participate in Upcoming Investor Conferences
Fonte
Capstan Therapeutics, Inc.
Emittente
Business Wire
1.00
0
27/08/2024
Biotecnologia
Salute
Farmaceutica
Oncologia
Eventi
Capstan Therapeutics to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
Fonte
Capstan Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0